PRPH - プロフェイズ・ラブズ (ProPhase Labs Inc.) プロフェイズ・ラブズ

 PRPHのチャート


 PRPHの企業情報

symbol PRPH
会社名 ProPhase Labs Inc (プロフェイズ・ラブズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 食品加工   医療関連(Health Care)
概要 事業概要 プロフェース・ラブス(ProPhase Labs Inc. )(旧名:ザ・クイグリー(The Quigley Corporation))はホメオパシー製品及び健康製品の製造・マーケティング・販売に従事する企業。同社はまた、人・獣医に使用される潜在自然ベースの健康製品及び栄養補助食品・薬用化粧品の研究・開発に従事する。同社は主に全国チェーン、地方、専門及び現地小売店舗を通して、顧客へ店頭販売(OTC)の風邪治療薬の製造、流通マーケティング及び販売を行う。同社の主要製品「Cold-EEZE」はグルコン酸亜鉛グリシン製品であり、普通感冒の症状の持続時間及び重症度を半分近く軽減させると治験で証明された。  プロフェイズ・ラブズは米国の医薬品メ―カ―。店頭販売用の風邪治療薬及び消費財、自然ベ―スの健康製品、栄養補助食品及び薬用化粧品などを研究、開発、製造、販売。ホメオパシ―療法や逆症療法化合物などの開発も行う。主な製品には、グルコン酸亜鉛トロ―チの「コ―ルドイ―ズ」がある。本社はペンシルベニア州。   ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.
本社所在地 621 N. Shady Retreat Road Doylestown PA 18901 USA
代表者氏名 Ted William Karkus テッド・ウィリアム・カルーカス
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 215-345-0919
設立年月日 32690
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 46人
url www.ProPhaseLabs.com
nasdaq_url https://www.nasdaq.com/symbol/prph
adr_tso
EBITDA EBITDA(百万ドル) -1.44300
終値(lastsale) 2.9792
時価総額(marketcap) 34386060.464
時価総額 時価総額(百万ドル) 34.16445
売上高 売上高(百万ドル) 13.78400
企業価値(EV) 企業価値(EV)(百万ドル) 23.72345
当期純利益 当期純利益(百万ドル) 0.98300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ProPhase Labs Inc revenues increased from $2.7M to $6.6M. Net loss before extraordinary items decreased 87% to $217K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development decrease of 33% to $174K (expense) Interest Expense decrease from $54K (expense) to $0K.

 PRPHのテクニカル分析


 PRPHのニュース

   ONVO, YEXT, CTRM and SLCA among midday movers  2021/05/28 16:39:43 Seeking Alpha
   Core Capital Goods Orders Post A Strong Gain In April  2021/05/28 10:00:00 Seeking Alpha
   34 Stocks Moving in Wednesday's Pre-Market Session  2021/03/31 11:08:44 Benzinga
Gainers Arcadia Biosciences, Inc. (NASDAQ: RKDA ) rose 52% to $3.54 in pre-market trading after the company announced better-than-expected Q4 sales. ClearOne, Inc. (NASDAQ: CLRO ) rose 29.9% to $4.00 in pre-market trading. ClearOne shares fell over 6% on Tuesday after the company reported Q4 earnings results. X Financial (NYSE: XYF ) rose 20% to $4.02 in pre-market trading after gaining around 10% on Tuesday. Hywin Holdings Ltd. (NASDAQ: HYW ) shares rose 16.5% to $11.40 in pre-market trading. The company, last week, priced its IPO at $10 per ADS. CASI Pharmaceuticals, Inc. (NASDAQ: CASI ) rose 15.1% to $2.29 in pre-market trading. The company, on Tuesday, reported FY20 results.. ProPhase Labs, Inc. (NASDAQ: PRPH ) rose 14.5% to $7.18 in pre-market trading after the company disclosed that it has acquired mobile app company VaccTrack, which confirms a user has been vaccinated against COVID-19, for an undisclosed amount. Greenlane Holdings, Inc. (NASDAQ: GNLN ) rose 14.4% to $4.68 in pre-market trading after the company and KushCo announced a merger agreement.
   Why ProPhase Labs Shares Jumped 32% Today  2021/03/31 03:54:51 Benzinga
Shares of ProPhase Labs Inc (NASDAQ: Full story available on Benzinga.com
   The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences  2020/10/07 11:30:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Inspire Medical Systems Inc (NYSE: INSP ) InVitae Corp (NYSE: NVTA ) Kura Oncology Inc (NASDAQ: KURA ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Inc (NASDAQ: PRLD ) ProPhase Labs Inc (NASDAQ: PRPH ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 6) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) (reacted to negative results for a mid-stage study of lenabasum in cystic fibrosis patients) Dyne Therapeutics Inc (NASDAQ: DYN ) Outset Medical Inc (NASDAQ: OM ) Teligent Inc (NASDAQ: TLGT ) Stocks In Focus Integra LifeSciences' Preliminary Q3 Revenues Exceed Estimate Medtech company Integra Lifesciences Holdings Corp (NASDAQ: IART ) preannounced third-quarter results, expecting revenues of $368 million to $370 million, down about 2.7%, but exceeding the company's guidance provided at …
   The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation  2020/10/06 12:24:11 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) argenx SE – ADR (NASDAQ: ARGX ) (presented positive new data from a Phase 3 trial evaluating efgartigimod in patients with generalized myasthenia gravis) Ascendis Pharma A/S (NASDAQ: ASND ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) C4 Therapeutics, Inc. (NASDAQ: CCCC ) (went public Friday) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) Cytokinetics, Inc. (NASDAQ: CYTK ) (reacted to presentations at the Heart Failure Society of America virtual meeting) Eidos Therapeutics Inc (NASDAQ: EIDX ) - announced a deal to be bought by BridgeBio Pharma Inc (NASDAQ: BBIO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) Myokardia Inc (NASDAQ: MYOK ) - announced a deal to be bought by Bristol-Myers Squibb Co (NYSE: BMY ) for $13.
   58 Biggest Movers From Friday  2020/10/05 08:32:53 Benzinga
Gainers Xtant Medical Holdings, Inc. (NYSE: XTNT ) shares climbed 91.4% to close at $1.57 on Friday after the company announced the closing of debt restructuring. American Renal Associates Holdings, Inc. (NYSE: ARA ) shares climbed 66.5% to close at $11.52 after the company reported an $11.50 per share cash offer from Nautic Partners. Nano-X Imaging Ltd. (NASDAQ: NNOX ) shares gained 56.2% to close at $37.44 after the company announced it will demonstrate its novel technology and medical imaging system at RSNA 2020, which is being held from November 29th to December 5th in Chicago. Westwater Resources, Inc. (NASDAQ: WWR ) surged 49.3% to close at $4.42. IDT Corporation (NYSE: IDT ) gained 39.1% to close at $9.57 after reporting higher earnings and sales for the fourth quarter. C4 Therapeutics, Inc. (NASDAQ: CCCC ) rose 34.2% to close at $25.49 after pricing its IPO at $19 per share. ProPhase Labs, Inc. (NASDAQ: PRPH ) surged 32.1% to close at $5.15. ProPhase Labs climbed 13% on Thursday after the company announced plans to explore the acquisition of one or more CLIA accredited labs suitable for COVID-19 and other testing.
   34 Stocks Moving in Wednesday's Pre-Market Session  2021/03/31 11:08:44 Benzinga
Gainers Arcadia Biosciences, Inc. (NASDAQ: RKDA ) rose 52% to $3.54 in pre-market trading after the company announced better-than-expected Q4 sales. ClearOne, Inc. (NASDAQ: CLRO ) rose 29.9% to $4.00 in pre-market trading. ClearOne shares fell over 6% on Tuesday after the company reported Q4 earnings results. X Financial (NYSE: XYF ) rose 20% to $4.02 in pre-market trading after gaining around 10% on Tuesday. Hywin Holdings Ltd. (NASDAQ: HYW ) shares rose 16.5% to $11.40 in pre-market trading. The company, last week, priced its IPO at $10 per ADS. CASI Pharmaceuticals, Inc. (NASDAQ: CASI ) rose 15.1% to $2.29 in pre-market trading. The company, on Tuesday, reported FY20 results.. ProPhase Labs, Inc. (NASDAQ: PRPH ) rose 14.5% to $7.18 in pre-market trading after the company disclosed that it has acquired mobile app company VaccTrack, which confirms a user has been vaccinated against COVID-19, for an undisclosed amount. Greenlane Holdings, Inc. (NASDAQ: GNLN ) rose 14.4% to $4.68 in pre-market trading after the company and KushCo announced a merger agreement.
   Why ProPhase Labs Shares Jumped 32% Today  2021/03/31 03:54:51 Benzinga
Shares of ProPhase Labs Inc (NASDAQ: Full story available on Benzinga.com
   The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences  2020/10/07 11:30:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Inspire Medical Systems Inc (NYSE: INSP ) InVitae Corp (NYSE: NVTA ) Kura Oncology Inc (NASDAQ: KURA ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Inc (NASDAQ: PRLD ) ProPhase Labs Inc (NASDAQ: PRPH ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 6) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) (reacted to negative results for a mid-stage study of lenabasum in cystic fibrosis patients) Dyne Therapeutics Inc (NASDAQ: DYN ) Outset Medical Inc (NASDAQ: OM ) Teligent Inc (NASDAQ: TLGT ) Stocks In Focus Integra LifeSciences' Preliminary Q3 Revenues Exceed Estimate Medtech company Integra Lifesciences Holdings Corp (NASDAQ: IART ) preannounced third-quarter results, expecting revenues of $368 million to $370 million, down about 2.7%, but exceeding the company's guidance provided at …
   The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation  2020/10/06 12:24:11 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) argenx SE – ADR (NASDAQ: ARGX ) (presented positive new data from a Phase 3 trial evaluating efgartigimod in patients with generalized myasthenia gravis) Ascendis Pharma A/S (NASDAQ: ASND ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) C4 Therapeutics, Inc. (NASDAQ: CCCC ) (went public Friday) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) Cytokinetics, Inc. (NASDAQ: CYTK ) (reacted to presentations at the Heart Failure Society of America virtual meeting) Eidos Therapeutics Inc (NASDAQ: EIDX ) - announced a deal to be bought by BridgeBio Pharma Inc (NASDAQ: BBIO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) Myokardia Inc (NASDAQ: MYOK ) - announced a deal to be bought by Bristol-Myers Squibb Co (NYSE: BMY ) for $13.
   58 Biggest Movers From Friday  2020/10/05 08:32:53 Benzinga
Gainers Xtant Medical Holdings, Inc. (NYSE: XTNT ) shares climbed 91.4% to close at $1.57 on Friday after the company announced the closing of debt restructuring. American Renal Associates Holdings, Inc. (NYSE: ARA ) shares climbed 66.5% to close at $11.52 after the company reported an $11.50 per share cash offer from Nautic Partners. Nano-X Imaging Ltd. (NASDAQ: NNOX ) shares gained 56.2% to close at $37.44 after the company announced it will demonstrate its novel technology and medical imaging system at RSNA 2020, which is being held from November 29th to December 5th in Chicago. Westwater Resources, Inc. (NASDAQ: WWR ) surged 49.3% to close at $4.42. IDT Corporation (NYSE: IDT ) gained 39.1% to close at $9.57 after reporting higher earnings and sales for the fourth quarter. C4 Therapeutics, Inc. (NASDAQ: CCCC ) rose 34.2% to close at $25.49 after pricing its IPO at $19 per share. ProPhase Labs, Inc. (NASDAQ: PRPH ) surged 32.1% to close at $5.15. ProPhase Labs climbed 13% on Thursday after the company announced plans to explore the acquisition of one or more CLIA accredited labs suitable for COVID-19 and other testing.

 関連キーワード  (食品加工 米国株 プロフェイズ・ラブズ PRPH ProPhase Labs Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)